sepiatec prep sfc100 (Sepiatec Inc)
90
Structured Review
Sepiatec Inc
sepiatec prep sfc100
Sepiatec Prep Sfc100, supplied by Sepiatec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sepiatec+prep+sfc100/prep+sfc100/us12304907-15971-0-11
Average 90 stars, based on 1 article reviews
Sepiatec Prep Sfc100, supplied by Sepiatec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sepiatec+prep+sfc100/prep+sfc100/us12304907-15971-0-11
Average 90 stars, based on 1 article reviews
sepiatec prep sfc100 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162 Article Snippet: The instrument used was a Article Title: Compounds and methods of use Article Snippet: N-(6-amino-5-methyl-3-pyridyl)-2-[2-(6-ethyl-3-pyridyl)-5-methyl-1-piperidyl]-2-oxo-acetamide (40 mg, 0.105 mmol) was separated by chiral Article Title: Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162 Article Snippet: The instrument used was a Article Title: Compounds and methods of use Article Snippet: N-(6-amino-5-methyl-3-pyridyl)-2-[2-(6-ethyl-3-pyridyl)-5-methyl-1-piperidyl]-2-oxo-acetamide (40 mg, 0.105 mmol) was separated by chiral Article Title: Bicyclic compounds and their uses Article Snippet: Chiral separation of rac-tert-butyl 5-(4-(2-((2-chloro-4-(trifluoromethyl)phenyl)amino)-2-oxoethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-2,5-diazabicyclo[4.2.0]octane-2-carboxylate: Preparative chiral SFC (instrument: Article Title: Discovery of BAY-390 , a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Article Snippet: After chiral separation by SFC (instrument: Article Title: HDAC inhibitors and therapeutic use thereof Article Snippet: 1H NMR (400 MHz, DMSO-d6) δ ppm 9.89 (s, 1H), 9.41 (s, 1H), 9.35 (s, 2H), 8.10-8.26 (m, 4H), 7.56 (dd, J=8.8, 5.5 Hz, 2H), 7.46 (d, J=1.8 Hz, 1H), 7.31 (dd, J=8.3, 2.0 Hz, 1H), 7.21 (t, J=8.9 Hz, 2H), 6.84 (d, J=8.3 Hz, 1H), 5.78 (s, 1H), 5.15 (s, 2H); 19F NMR (376 MHz, DMSO-d6) δ ppm−117.469; LCMS (ESI) [M+H]+ m/z: calcd 448.1, found 448.2; Purification:Article Title: 1,3-thiazol-2-yl substituted benzamides Article Snippet: .. Chiral Purification Methods: Flow Detector rate wave- (ml/ length Isocratic Method Column Type min) (nm) Conditions 1 Amy-C (20 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 2 Lux C3 (21.2 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 3 Lux C4 (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 4 Lux C4 (20 mm × 21 212 50:50 Heptane/ 250 mm, 5 um) IPA (DEA added as a modifier) 5 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) EtOH/CO2 6 Lux C1 (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v DEA) 7 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 8 Amy-C (20 mm × 50 210 40:60 250 mm, 5 um) EtOH/CO2 (0.1% v/v NH3) 9 Amy-C (20 mm × 42 210 70:30 250 mm, 5 um) Heptane/IPA (0.1% v/v NH3) 10 Amy-C (20 mm × 50 220 35:65 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 11 Lux C1 (20 mm × 21 220 70:30 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 12 Lux C1 (20 mm × 21 220 50:50 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 13 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 14 Amy-C (20 mm × 50 210 15:85 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 15 Amy-C (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) Preparative Chiral HPLC Methods Method A: Instrument: Labomatic HD5000, Labocord-5000; Gilson GX-241, Labcol Vario 4000; column: Chiralpak IE 5μ 250×30 mm; eluent A: ethanol+0.1 Vol-% diethylamine (99%); eluent B: tert.-butyl methyl ether; isokratic: 5% A+95% B; flow 50.0 ml/min; UV 325 nm Method B: Instrument: Indirect Immunoperoxidase Assay:Article Title: 1,3-thiazol-2-yl substituted benzamides Article Snippet: .. Chiral Purification Methods: Flow Detector rate wave- (ml/ length Isocratic Method Column Type min) (nm) Conditions 1 Amy-C (20 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 2 Lux C3 (21.2 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 3 Lux C4 (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 4 Lux C4 (20 mm × 21 212 50:50 Heptane/ 250 mm, 5 um) IPA (DEA added as a modifier) 5 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) EtOH/CO2 6 Lux C1 (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v DEA) 7 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 8 Amy-C (20 mm × 50 210 40:60 250 mm, 5 um) EtOH/CO2 (0.1% v/v NH3) 9 Amy-C (20 mm × 42 210 70:30 250 mm, 5 um) Heptane/IPA (0.1% v/v NH3) 10 Amy-C (20 mm × 50 220 35:65 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 11 Lux C1 (20 mm × 21 220 70:30 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 12 Lux C1 (20 mm × 21 220 50:50 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 13 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 14 Amy-C (20 mm × 50 210 15:85 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 15 Amy-C (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) Preparative Chiral HPLC Methods Method A: Instrument: Labomatic HD5000, Labocord-5000; Gilson GX-241, Labcol Vario 4000; column: Chiralpak IE 5μ 250×30 mm; eluent A: ethanol+0.1 Vol-% diethylamine (99%); eluent B: tert.-butyl methyl ether; isokratic: 5% A+95% B; flow 50.0 ml/min; UV 325 nm Method B: Instrument: High Performance Liquid Chromatography:Article Title: 1,3-thiazol-2-yl substituted benzamides Article Snippet: .. Chiral Purification Methods: Flow Detector rate wave- (ml/ length Isocratic Method Column Type min) (nm) Conditions 1 Amy-C (20 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 2 Lux C3 (21.2 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 3 Lux C4 (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 4 Lux C4 (20 mm × 21 212 50:50 Heptane/ 250 mm, 5 um) IPA (DEA added as a modifier) 5 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) EtOH/CO2 6 Lux C1 (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v DEA) 7 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 8 Amy-C (20 mm × 50 210 40:60 250 mm, 5 um) EtOH/CO2 (0.1% v/v NH3) 9 Amy-C (20 mm × 42 210 70:30 250 mm, 5 um) Heptane/IPA (0.1% v/v NH3) 10 Amy-C (20 mm × 50 220 35:65 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 11 Lux C1 (20 mm × 21 220 70:30 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 12 Lux C1 (20 mm × 21 220 50:50 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 13 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 14 Amy-C (20 mm × 50 210 15:85 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 15 Amy-C (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) Preparative Chiral HPLC Methods Method A: Instrument: Labomatic HD5000, Labocord-5000; Gilson GX-241, Labcol Vario 4000; column: Chiralpak IE 5μ 250×30 mm; eluent A: ethanol+0.1 Vol-% diethylamine (99%); eluent B: tert.-butyl methyl ether; isokratic: 5% A+95% B; flow 50.0 ml/min; UV 325 nm Method B: Instrument: Hydrophilic Interaction Liquid Chromatography:Article Title: 1,3-thiazol-2-yl substituted benzamides Article Snippet: .. Chiral Purification Methods: Flow Detector rate wave- (ml/ length Isocratic Method Column Type min) (nm) Conditions 1 Amy-C (20 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 2 Lux C3 (21.2 mm × 50 210 20:80 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 3 Lux C4 (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 4 Lux C4 (20 mm × 21 212 50:50 Heptane/ 250 mm, 5 um) IPA (DEA added as a modifier) 5 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) EtOH/CO2 6 Lux C1 (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v DEA) 7 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 8 Amy-C (20 mm × 50 210 40:60 250 mm, 5 um) EtOH/CO2 (0.1% v/v NH3) 9 Amy-C (20 mm × 42 210 70:30 250 mm, 5 um) Heptane/IPA (0.1% v/v NH3) 10 Amy-C (20 mm × 50 220 35:65 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 11 Lux C1 (20 mm × 21 220 70:30 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 12 Lux C1 (20 mm × 21 220 50:50 250 mm, 5 um) Heptane/EtOH (0.1% v/v DEA) 13 Amy-C (20 mm × 50 210 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 14 Amy-C (20 mm × 50 210 15:85 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) 15 Amy-C (20 mm × 50 215 25:75 250 mm, 5 um) MeOH/CO2 (0.1% v/v NH3) Preparative Chiral HPLC Methods Method A: Instrument: Labomatic HD5000, Labocord-5000; Gilson GX-241, Labcol Vario 4000; column: Chiralpak IE 5μ 250×30 mm; eluent A: ethanol+0.1 Vol-% diethylamine (99%); eluent B: tert.-butyl methyl ether; isokratic: 5% A+95% B; flow 50.0 ml/min; UV 325 nm Method B: Instrument: |